臓器移植におけるLiquid Biopsy(ドナー由来遊離DNA断片測定)

臓器移植後の長期グラフト機能維持は今後の移植医療の重要課題である.近年,グラフト障害を低侵襲かつ高感度にモニタリング可能な血清バイオマーカーとして,ドナー由来遊離DNA断片(donor-derived cell-free DNA)が注目され, 急性拒絶反応の早期診断,治療効果判定,侵襲を伴う検査の減少,外来レベルでの安全なモニタリング等における有用性が報告されている.さらには,既存のバイオマーカーとの組み合わせでグラフトの長期生存率向上に寄与することも期待される....

Full description

Saved in:
Bibliographic Details
Published inOrgan Biology Vol. 31; no. 1; pp. 017 - 023
Main Authors 尾原, 秀明, 長谷川, 康, 篠田, 昌宏, 山田, 洋平, 西郷, 健一, 藤野, 明浩, 北川, 雄光, 井ノ上, 逸朗, 金森, 洋樹, 光永, 滋樹
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本臓器保存生物医学会 2024
Subjects
Online AccessGet full text
ISSN1340-5152
2188-0204
DOI10.11378/organbio.31.017

Cover

Abstract 臓器移植後の長期グラフト機能維持は今後の移植医療の重要課題である.近年,グラフト障害を低侵襲かつ高感度にモニタリング可能な血清バイオマーカーとして,ドナー由来遊離DNA断片(donor-derived cell-free DNA)が注目され, 急性拒絶反応の早期診断,治療効果判定,侵襲を伴う検査の減少,外来レベルでの安全なモニタリング等における有用性が報告されている.さらには,既存のバイオマーカーとの組み合わせでグラフトの長期生存率向上に寄与することも期待される.
AbstractList 臓器移植後の長期グラフト機能維持は今後の移植医療の重要課題である.近年,グラフト障害を低侵襲かつ高感度にモニタリング可能な血清バイオマーカーとして,ドナー由来遊離DNA断片(donor-derived cell-free DNA)が注目され, 急性拒絶反応の早期診断,治療効果判定,侵襲を伴う検査の減少,外来レベルでの安全なモニタリング等における有用性が報告されている.さらには,既存のバイオマーカーとの組み合わせでグラフトの長期生存率向上に寄与することも期待される.
Author 金森, 洋樹
篠田, 昌宏
西郷, 健一
長谷川, 康
北川, 雄光
山田, 洋平
藤野, 明浩
井ノ上, 逸朗
尾原, 秀明
光永, 滋樹
Author_xml – sequence: 1
  fullname: 尾原, 秀明
  organization: 慶應義塾大学医学部 外科学(一般・消化器)
– sequence: 1
  fullname: 長谷川, 康
  organization: 慶應義塾大学医学部 外科学(一般・消化器)
– sequence: 1
  fullname: 篠田, 昌宏
  organization: 国立遺伝学研究所人類遺伝研究室
– sequence: 1
  fullname: 山田, 洋平
  organization: 慶應義塾大学医学部 外科学(小児)
– sequence: 1
  fullname: 西郷, 健一
  organization: 独立行政法人地域医療機能推進機構千葉病院移植外科
– sequence: 1
  fullname: 藤野, 明浩
  organization: 慶應義塾大学医学部 外科学(小児)
– sequence: 1
  fullname: 北川, 雄光
  organization: 慶應義塾大学医学部 外科学(一般・消化器)
– sequence: 1
  fullname: 井ノ上, 逸朗
  organization: 国立遺伝学研究所人類遺伝研究室
– sequence: 1
  fullname: 金森, 洋樹
  organization: 慶應義塾大学医学部 外科学(小児)
– sequence: 1
  fullname: 光永, 滋樹
  organization: 国立遺伝学研究所人類遺伝研究室
BookMark eNo9kD1Lw0AAhg-pYFvdHf0DqfeRy13GtmoVil10DpdLribUpiZ16Bg71FYcRBFUXERR8APcBPtvQlM79S-o-LE87_DAOzw5kGkGTReARQQLCBHGl4OwLpq2FxQIKkDEZkAWI841iKGeAVlEdKhRRPEcyEWRDyHlOjKzoPbROx1dPIzv39Pb4yR-TOJBEp8kB0dVb2_fc5ZKXtCKOtPhYdLtJ91B0h2Oz17T67tJPJhc3axsFtPz53G_l749jV4up8P-PJhVohG5C7-bB9trq1vlda1aq2yUi1XNRxwLDQtbGdiQJjOxDZlSuim54VDGlE6o0DEzuS0MSAWTAhomolBJx-FSSe4i6ZA8KP38-lFb1F2rFXq7IuxYImx7suFafzUsgiz0ja8k_1LuiNDyBfkEu811Kg
ContentType Journal Article
Copyright 2023 日本臓器保存生物医学会
Copyright_xml – notice: 2023 日本臓器保存生物医学会
DOI 10.11378/organbio.31.017
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EISSN 2188-0204
EndPage 023
ExternalDocumentID article_organbio_31_1_31_017_article_char_ja
GroupedDBID ABDBF
ABJNI
ALMA_UNASSIGNED_HOLDINGS
JMI
JSF
JSH
KQ8
MOJWN
RJT
RZJ
ID FETCH-LOGICAL-j182a-2abf626c9792b07ff49c86d577f435a42798ba605a7ca069150fcdd8cfc8e1cd3
ISSN 1340-5152
IngestDate Wed Sep 03 06:31:24 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 1
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j182a-2abf626c9792b07ff49c86d577f435a42798ba605a7ca069150fcdd8cfc8e1cd3
OpenAccessLink https://www.jstage.jst.go.jp/article/organbio/31/1/31_017/_article/-char/ja
PageCount 7
ParticipantIDs jstage_primary_article_organbio_31_1_31_017_article_char_ja
PublicationCentury 2000
PublicationDate 2024
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – year: 2024
  text: 2024
PublicationDecade 2020
PublicationTitle Organ Biology
PublicationTitleAlternate Organ Biology
PublicationYear 2024
Publisher 一般社団法人 日本臓器保存生物医学会
Publisher_xml – name: 一般社団法人 日本臓器保存生物医学会
References 5) Fernández-Galán E, Badenas C, Fondevila C, et al. Monitoring of Donor-Derived Cell- Free DNA by Short Tandem Repeats: Concentration of Total Cell-Free DNA and Fragment Size for Acute Rejection Risk Assessment in Liver Transplantation. Liver Transpl 2022;28: 257-268
12) Tanaka S, Sugimoto S, Toyooka S, et al. Donor-derived cell-free DNA is associated with acute rejection and decreased oxygenation in primary graft dysfunction after living donor-lobar lung transplantation. Sci Rep 2018;8:15366
8) De Vlaminck I, Martin L, Kertesz M, et al. Noninvasive monitoring of infection and rejection after lung transplantation. Proc Natl Acad Sci USA 2015;112:13336-13341
3) Knight SR, Thorne A, Lo Faro ML. Donor-specific Cell-free DNA as a Biomarker in Solid Organ Transplantation. A Systematic Review. Transplantation 2019;103:273-283
20) Levitsky J, Kandpal M, Guo K, Kleiboeker S, Sinha R, Abecassis M. Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients. Am J Transplant 2022;22:532-540
13) Beck J, Bierau S, Balzer S, et al. Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury. Clin Chem 2013;59:1732-1741
15) Zhang J, Tong KL, Li PK, et al. Presence of donor- and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: urinary DNA chimerism. Clin Chem 1999;45:1741-1746
1) Fact Book 2022 on Organ Transplantation in Japan. http://www.asas.or.jp/jst/pdf/factbook/factbook2022.pdf
9) Schutz E, Fischer A, Beck J, et al. Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study. PLoS Med 2017;14:e1002286
16) Bloom RD, Bromberg JS, Poggio ED, et al. Cell-free DNA and active rejection in kidney allografts. J Am Soc Nephrol 2017;28(7):2221-2232
23) Michael K, Rohan M, Sean AE, et al. Comparison of donor-derived cell-free DNA between single versus double lung transplant recipients. Am J Transplant 2022;22:2451-2457
2) Lo YM, Tein MS, Pang CC, et al. Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients. Lancet 1998;351:1329-1330
4) Verhoeven J, Boer K, Van Schaik RHN, et al. Liquid Biopsies to Monitor Solid Organ Transplant Function: A Review of New Biomarkers. Ther Drug Monit 2018;40: 515-25.
7) De Vlaminck I, Valantine HA, Snyder TM, et al.Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med 2014;6:241ra77
22) Michael K, Cedric M, Sean AE, et al. Biological Variation of Donor-Derived Cell-Free DNA in Stable Lung Transplant Recipients. J Appl Lab Med 2022;30:901-909
10) Bloom R, Bromberg J, Poggio E, et al. Donor-derived cell-free DNA correlates with antibody-mediated rejection in kidney allografts. 2017 American Transplant Congress (Abstract No.397) https://atcmeetingabstracts.com/abstract/donor-derived-cell-free-dna-correlates-with-antibody-mediated-rejection-in-kidney-allografts/ (accessed on 2023/11/04
19) Kanamori H, Yamada Y, Kuroda T et al. Noninvasive graft monitoring using donor-derived cell-free DNA in Japanese liver transplantation. Hepatol Res 2023 Oct 18. DOI: 10.1111/hepr.13978. https://onlinelibrary.wiley.com/doi/epdf/10.1111/hepr.13978
14) Lee H, Park YM, We YM, et al. Evaluation of digital PCR as a technique for monitoring acute rejection in kidney transplantation. Genomics Inform 2017;15:2-10
21) Sean AE, Palak S, Hannah AV, et al. Cell-Free DNA to Detect Heart Allograft Acute Rejection. Circulation 2021;143:1184-1197
6) Dengu F. Next-generation sequencing methods to detect donor-derived cell-free DNA after transplantation. Transplant Rev (Orlando) 2020;34:100542
18) Sigdel TK, Vitalone MJ, Tran TQ, et al. A rapid noninvasive assay for the detection of renal transplant injury. Transplantation 2013;96:97-101
11) U.S. National Library of Medicine. ClinicalTrials.gov, https://classic.clinicaltrials.gov/ct2/home searched by "cfDNA, transplant" (accessed on 2023/11/04
17) Jordan SC, Bunnapradist S, Bromberg JS, et al. Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients. Am J Transplant 2018;18(Suppl 4):254
References_xml – reference: 7) De Vlaminck I, Valantine HA, Snyder TM, et al.Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med 2014;6:241ra77
– reference: 10) Bloom R, Bromberg J, Poggio E, et al. Donor-derived cell-free DNA correlates with antibody-mediated rejection in kidney allografts. 2017 American Transplant Congress (Abstract No.397) https://atcmeetingabstracts.com/abstract/donor-derived-cell-free-dna-correlates-with-antibody-mediated-rejection-in-kidney-allografts/ (accessed on 2023/11/04)
– reference: 6) Dengu F. Next-generation sequencing methods to detect donor-derived cell-free DNA after transplantation. Transplant Rev (Orlando) 2020;34:100542
– reference: 5) Fernández-Galán E, Badenas C, Fondevila C, et al. Monitoring of Donor-Derived Cell- Free DNA by Short Tandem Repeats: Concentration of Total Cell-Free DNA and Fragment Size for Acute Rejection Risk Assessment in Liver Transplantation. Liver Transpl 2022;28: 257-268
– reference: 14) Lee H, Park YM, We YM, et al. Evaluation of digital PCR as a technique for monitoring acute rejection in kidney transplantation. Genomics Inform 2017;15:2-10
– reference: 16) Bloom RD, Bromberg JS, Poggio ED, et al. Cell-free DNA and active rejection in kidney allografts. J Am Soc Nephrol 2017;28(7):2221-2232
– reference: 18) Sigdel TK, Vitalone MJ, Tran TQ, et al. A rapid noninvasive assay for the detection of renal transplant injury. Transplantation 2013;96:97-101
– reference: 21) Sean AE, Palak S, Hannah AV, et al. Cell-Free DNA to Detect Heart Allograft Acute Rejection. Circulation 2021;143:1184-1197
– reference: 3) Knight SR, Thorne A, Lo Faro ML. Donor-specific Cell-free DNA as a Biomarker in Solid Organ Transplantation. A Systematic Review. Transplantation 2019;103:273-283
– reference: 20) Levitsky J, Kandpal M, Guo K, Kleiboeker S, Sinha R, Abecassis M. Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients. Am J Transplant 2022;22:532-540
– reference: 1) Fact Book 2022 on Organ Transplantation in Japan. http://www.asas.or.jp/jst/pdf/factbook/factbook2022.pdf
– reference: 23) Michael K, Rohan M, Sean AE, et al. Comparison of donor-derived cell-free DNA between single versus double lung transplant recipients. Am J Transplant 2022;22:2451-2457
– reference: 2) Lo YM, Tein MS, Pang CC, et al. Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients. Lancet 1998;351:1329-1330
– reference: 11) U.S. National Library of Medicine. ClinicalTrials.gov, https://classic.clinicaltrials.gov/ct2/home searched by "cfDNA, transplant" (accessed on 2023/11/04)
– reference: 8) De Vlaminck I, Martin L, Kertesz M, et al. Noninvasive monitoring of infection and rejection after lung transplantation. Proc Natl Acad Sci USA 2015;112:13336-13341
– reference: 12) Tanaka S, Sugimoto S, Toyooka S, et al. Donor-derived cell-free DNA is associated with acute rejection and decreased oxygenation in primary graft dysfunction after living donor-lobar lung transplantation. Sci Rep 2018;8:15366
– reference: 17) Jordan SC, Bunnapradist S, Bromberg JS, et al. Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients. Am J Transplant 2018;18(Suppl 4):254
– reference: 19) Kanamori H, Yamada Y, Kuroda T et al. Noninvasive graft monitoring using donor-derived cell-free DNA in Japanese liver transplantation. Hepatol Res 2023 Oct 18. DOI: 10.1111/hepr.13978. https://onlinelibrary.wiley.com/doi/epdf/10.1111/hepr.13978
– reference: 22) Michael K, Cedric M, Sean AE, et al. Biological Variation of Donor-Derived Cell-Free DNA in Stable Lung Transplant Recipients. J Appl Lab Med 2022;30:901-909
– reference: 4) Verhoeven J, Boer K, Van Schaik RHN, et al. Liquid Biopsies to Monitor Solid Organ Transplant Function: A Review of New Biomarkers. Ther Drug Monit 2018;40: 515-25.
– reference: 13) Beck J, Bierau S, Balzer S, et al. Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury. Clin Chem 2013;59:1732-1741
– reference: 9) Schutz E, Fischer A, Beck J, et al. Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study. PLoS Med 2017;14:e1002286
– reference: 15) Zhang J, Tong KL, Li PK, et al. Presence of donor- and recipient-derived DNA in cell-free urine samples of renal transplantation recipients: urinary DNA chimerism. Clin Chem 1999;45:1741-1746
SSID ssj0058419
Score 1.9619431
Snippet 臓器移植後の長期グラフト機能維持は今後の移植医療の重要課題である.近年,グラフト障害を低侵襲かつ高感度にモニタリング可能な血清バイオマーカーとして,ドナー由来...
SourceID jstage
SourceType Publisher
StartPage 017
SubjectTerms グラフト障害
ドナー由来cell free DNA
リキッドバイオプシー
臓器移植
Title 臓器移植におけるLiquid Biopsy(ドナー由来遊離DNA断片測定)
URI https://www.jstage.jst.go.jp/article/organbio/31/1/31_017/_article/-char/ja
Volume 31
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Organ Biology, 2024, Vol.31(1), pp.017-023
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2188-0204
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0058419
  issn: 1340-5152
  databaseCode: KQ8
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 2188-0204
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0058419
  issn: 1340-5152
  databaseCode: ABDBF
  dateStart: 20230901
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1Na9VAMNT24kUUFb_pwT2mJtkku4un3fcSimi9tNBbSPIS6Du0VduD3p491FY8iCKoeBFFwQ_wJvj-TeirPfXk3Znd5PW19WAVQphkZ2bnI8vOLDtZy7pK_SALmevaoQghQSl4aIusEHbqwdzCKHfKEgucb82E03P-jflgfuzYr5FdS6sr2VT-4I91Jf_iVXgHfsUq2SN4dsgUXgAM_oU7eBjuf-VjEnECybygJAqIEERyEjEiGVGKRCGRECe2SUQhWiRS1QCXNSBcDXiEq5sLd1YXOngu5fK9-ySKiWoRznUzXKIBZA1AK3QjfKJc7Ea0iQxIJBrugghFpNeekboV5GgjPvABWeGN4kS2UGIZESGb7sRomKwrROtzModr_kiiHKIiBDjQxvh91BpzR3cG9oj28EESIGFoJiRkmgNDgTUhPEh43sMHTjGRTqOdY9AM20ZiHu-Tx9VGOICvwPBKNwui6OjCire3pEoiH02BgnO0ttRWBZ8ZBdGGVDOjqAUiS7zQBU6jLtOWB6ClyQ9_DUAVo74oexv1MKKC6YxHpNDGbOkvRuPIUFO1wDUjExb1HRtiUjOjFfodRG3cxqLn0VmunmtHR7OZshxTO1tHP46p_j48sVKG1SL6qLFsYWmKulNDwn2_K68HQ9JgJtRNXLwBetI0YkVh0oW0ZsLDZbRxa0KqtoqbEAqCYn0iz1C5Zn8BCHHtgAgQOXYhj2r2YOqwcPakdaLO5yal6fKUNdZNT1u3f64_23r5cfvDj8G7J1XvU9XbrHpPq4ePzUCbNANtt_-oWtuo1jartf7282-DN-93eps7r9_CwBm8-LK9sT74_nnr66vd_sYZay6OZlvTdn1yid2FfD21vTQrQy_MBRNe5rCy9EXOw07AWAnpSep7TPAsDZ0gZXnqhAKysjLvdHhe5rxw8w49a40vLi0W56xJx-9kQYabESn3izTLaAEsaejnjJdB7p-3rhv9k2Xze5rkKB648F_UF63jOHDMiuQla3zl7mpxGWL0lexK7dHfm9jA7w
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%87%93%E5%99%A8%E7%A7%BB%E6%A4%8D%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8BLiquid+Biopsy%EF%BC%88%E3%83%89%E3%83%8A%E3%83%BC%E7%94%B1%E6%9D%A5%E9%81%8A%E9%9B%A2DNA%E6%96%AD%E7%89%87%E6%B8%AC%E5%AE%9A%EF%BC%89&rft.jtitle=Organ+Biology&rft.au=%E5%B0%BE%E5%8E%9F%2C+%E7%A7%80%E6%98%8E&rft.au=%E9%95%B7%E8%B0%B7%E5%B7%9D%2C+%E5%BA%B7&rft.au=%E7%AF%A0%E7%94%B0%2C+%E6%98%8C%E5%AE%8F&rft.au=%E5%B1%B1%E7%94%B0%2C+%E6%B4%8B%E5%B9%B3&rft.date=2024&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA%E3%80%80%E6%97%A5%E6%9C%AC%E8%87%93%E5%99%A8%E4%BF%9D%E5%AD%98%E7%94%9F%E7%89%A9%E5%8C%BB%E5%AD%A6%E4%BC%9A&rft.issn=1340-5152&rft.eissn=2188-0204&rft.volume=31&rft.issue=1&rft.spage=017&rft.epage=023&rft_id=info:doi/10.11378%2Forganbio.31.017&rft.externalDocID=article_organbio_31_1_31_017_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1340-5152&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1340-5152&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1340-5152&client=summon